Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
81 | 26583 | 36.1 | 79% |
Classes in level above (level 3) |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MYELODYSPLASTIC SYNDROMES | Author keyword | 875 | 63% | 3% | 874 |
2 | ACUTE MYELOID LEUKEMIA | Author keyword | 822 | 41% | 6% | 1566 |
3 | LEUKEMIA | Journal | 552 | 26% | 7% | 1859 |
4 | MYELODYSPLASTIC SYNDROME | Author keyword | 528 | 46% | 3% | 868 |
5 | CANCER GENETICS AND CYTOGENETICS | Journal | 492 | 26% | 6% | 1604 |
6 | ACUTE LYMPHOBLASTIC LEUKEMIA | Author keyword | 447 | 34% | 4% | 1063 |
7 | AML | Author keyword | 374 | 37% | 3% | 809 |
8 | FLT3 | Author keyword | 337 | 73% | 1% | 261 |
9 | MINIMAL RESIDUAL DISEASE | Author keyword | 276 | 41% | 2% | 522 |
10 | AZACITIDINE | Author keyword | 271 | 79% | 1% | 172 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYELODYSPLASTIC SYNDROMES | 875 | 63% | 3% | 874 | Search MYELODYSPLASTIC+SYNDROMES | Search MYELODYSPLASTIC+SYNDROMES |
2 | ACUTE MYELOID LEUKEMIA | 822 | 41% | 6% | 1566 | Search ACUTE+MYELOID+LEUKEMIA | Search ACUTE+MYELOID+LEUKEMIA |
3 | MYELODYSPLASTIC SYNDROME | 528 | 46% | 3% | 868 | Search MYELODYSPLASTIC+SYNDROME | Search MYELODYSPLASTIC+SYNDROME |
4 | ACUTE LYMPHOBLASTIC LEUKEMIA | 447 | 34% | 4% | 1063 | Search ACUTE+LYMPHOBLASTIC+LEUKEMIA | Search ACUTE+LYMPHOBLASTIC+LEUKEMIA |
5 | AML | 374 | 37% | 3% | 809 | Search AML | Search AML |
6 | FLT3 | 337 | 73% | 1% | 261 | Search FLT3 | Search FLT3 |
7 | MINIMAL RESIDUAL DISEASE | 276 | 41% | 2% | 522 | Search MINIMAL+RESIDUAL+DISEASE | Search MINIMAL+RESIDUAL+DISEASE |
8 | AZACITIDINE | 271 | 79% | 1% | 172 | Search AZACITIDINE | Search AZACITIDINE |
9 | PHILADELPHIA CHROMOSOME | 250 | 62% | 1% | 256 | Search PHILADELPHIA+CHROMOSOME | Search PHILADELPHIA+CHROMOSOME |
10 | MLL | 214 | 64% | 1% | 208 | Search MLL | Search MLL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACUTE MYELOGENOUS LEUKEMIA | 1786 | 46% | 11% | 2933 |
2 | ACUTE MYELOID LEUKEMIA | 1607 | 27% | 19% | 5181 |
3 | ACUTE NONLYMPHOCYTIC LEUKEMIA | 1266 | 60% | 5% | 1396 |
4 | INTERNAL TANDEM DUPLICATION | 1027 | 75% | 3% | 745 |
5 | MINIMAL RESIDUAL DISEASE | 656 | 39% | 5% | 1336 |
6 | AML | 628 | 56% | 3% | 761 |
7 | ACUTE LYMPHOBLASTIC LEUKEMIA | 540 | 17% | 11% | 2958 |
8 | HIGH DOSE CYTARABINE | 488 | 73% | 1% | 374 |
9 | AML1 GENE | 421 | 90% | 1% | 182 |
10 | ACUTE LYMPHOCYTIC LEUKEMIA | 383 | 40% | 3% | 745 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKEMIA | 552 | 26% | 7% | 1859 |
2 | CANCER GENETICS AND CYTOGENETICS | 492 | 26% | 6% | 1604 |
3 | LEUKEMIA RESEARCH | 249 | 20% | 4% | 1137 |
4 | BRITISH JOURNAL OF HAEMATOLOGY | 154 | 11% | 5% | 1372 |
5 | LEUKEMIA & LYMPHOMA | 103 | 12% | 3% | 826 |
6 | HAEMATOLOGICA | 61 | 13% | 2% | 438 |
7 | GENES CHROMOSOMES & CANCER | 49 | 12% | 1% | 375 |
8 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 45 | 11% | 1% | 386 |
9 | ANNALS OF HEMATOLOGY | 44 | 11% | 1% | 374 |
10 | BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 28 | 18% | 1% | 141 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | 2010 | 706 | 295 | 72% |
The World Health Organization (WHO) classification of the myeloid neoplasms | 2002 | 1098 | 85 | 75% |
Drug therapy - Treatment of acute lymphoblastic leukemia | 2006 | 818 | 99 | 59% |
Therapeutic Advances in Acute Myeloid Leukemia | 2011 | 217 | 71 | 82% |
Acute lymphoblastic leukaemia | 2008 | 501 | 161 | 53% |
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update | 2011 | 206 | 132 | 80% |
Medical progress - Acute myeloid leukemia | 1999 | 711 | 105 | 70% |
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease - Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia | 1999 | 581 | 179 | 82% |
Acute myeloid leukaemia | 2006 | 460 | 139 | 71% |
The roles of FLT3 in hematopoiesis and leukemia | 2002 | 622 | 131 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKAEMIA CYTOGENET GRP | 141 | 89% | 0.2% | 64 |
2 | LEUKEMIA | 102 | 21% | 1.7% | 444 |
3 | LEUKEMIA DIAGNOST | 73 | 73% | 0.2% | 55 |
4 | HEMATOL ONCOL CLIN IMMUNOL | 57 | 46% | 0.3% | 92 |
5 | RIC TETTAMANTI | 50 | 77% | 0.1% | 34 |
6 | LEUKEMIA PROGRAM | 45 | 53% | 0.2% | 59 |
7 | HEMATOL ONCOL BLOOD DISORDERS | 42 | 41% | 0.3% | 78 |
8 | CYTOGENET | 38 | 11% | 1.2% | 313 |
9 | HEMATOPATHOL | 33 | 12% | 1.0% | 256 |
10 | LEUKAEMIA FUND CYTOGENET GRP | 27 | 92% | 0.0% | 11 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000013620 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
2 | 0.0000013244 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
3 | 0.0000013120 | CHILDHOOD CANCER//CHILDHOOD LEUKAEMIA//CHILDHOOD LEUKEMIA |
4 | 0.0000011912 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
5 | 0.0000011359 | HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA |
6 | 0.0000011044 | GRANULOCYTIC SARCOMA//CHLOROMA//TUMOR LYSIS SYNDROME |
7 | 0.0000010033 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
8 | 0.0000008782 | ETS 1//PU1//HEMANGIOBLAST |
9 | 0.0000008538 | L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE |
10 | 0.0000008306 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |